Neutralizing antibodies against SARS-CoV-2 variants following mRNA booster vaccination in adults older than 65 years.

Durier C, Ninove L, Lefebvre M, Radenne A, Desaint C, Ropers J, Bauer R, Lebbah S, Carette D, Lachatre M, Lecompte AS, Deplanque D, Botelho-Nevers E, Conrad A, Dussol B, Maakaroun-Vermesse Z, Melica G, Nicolas JF, Verdon R, Kiladjian J, Loubet P, Schmidt-Mutter C, Dualé C, Ansart S, Priet S, Levier A, Molino D, Vieillard LV, Parfait B, Lelièvre JD, Tartour E, de Lamballerie X, Launay O, ANRS0002S CoviCompareP Group, AP-HP CoviCompareM Group, Biological resource centers, Laboratories, Trial coordination, Sponsor, Scientific Committee

Open source

DOI
10.1038/s41598-022-24409-w
Published
2022 Nov 27
Container
Scientific reports
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1038/s41598-022-24409-w,
  title = {Neutralizing antibodies against SARS-CoV-2 variants following mRNA booster vaccination in adults older than 65 years.},
  author = {Durier C and Ninove L and Lefebvre M and Radenne A and Desaint C and Ropers J and Bauer R and Lebbah S and Carette D and Lachatre M and Lecompte AS and Deplanque D and Botelho-Nevers E and Conrad A and Dussol B and Maakaroun-Vermesse Z and Melica G and Nicolas JF and Verdon R and Kiladjian J and Loubet P and Schmidt-Mutter C and Dualé C and Ansart S and Priet S and Levier A and Molino D and Vieillard LV and Parfait B and Lelièvre JD and Tartour E and de Lamballerie X and Launay O and ANRS0002S CoviCompareP Group and AP-HP CoviCompareM Group and Biological resource centers and Laboratories and Trial coordination and Sponsor and Scientific Committee},
  year = {2022},
  journal = {Scientific reports},
  doi = {10.1038/s41598-022-24409-w},
  url = {https://doi.org/10.1038/s41598-022-24409-w}
}

RIS

TY  - JOUR
TI  - Neutralizing antibodies against SARS-CoV-2 variants following mRNA booster vaccination in adults older than 65 years.
AU  - Durier C
AU  - Ninove L
AU  - Lefebvre M
AU  - Radenne A
AU  - Desaint C
AU  - Ropers J
AU  - Bauer R
AU  - Lebbah S
AU  - Carette D
AU  - Lachatre M
AU  - Lecompte AS
AU  - Deplanque D
AU  - Botelho-Nevers E
AU  - Conrad A
AU  - Dussol B
AU  - Maakaroun-Vermesse Z
AU  - Melica G
AU  - Nicolas JF
AU  - Verdon R
AU  - Kiladjian J
AU  - Loubet P
AU  - Schmidt-Mutter C
AU  - Dualé C
AU  - Ansart S
AU  - Priet S
AU  - Levier A
AU  - Molino D
AU  - Vieillard LV
AU  - Parfait B
AU  - Lelièvre JD
AU  - Tartour E
AU  - de Lamballerie X
AU  - Launay O
AU  - ANRS0002S CoviCompareP Group
AU  - AP-HP CoviCompareM Group
AU  - Biological resource centers
AU  - Laboratories
AU  - Trial coordination
AU  - Sponsor
AU  - Scientific Committee
PY  - 2022
JO  - Scientific reports
DO  - 10.1038/s41598-022-24409-w
UR  - https://doi.org/10.1038/s41598-022-24409-w
ER  - 

APA

C, D., L, N., M, L., A, R., C, D., J, R., R, B., S, L., D, C., M, L., AS, L., D, D., E, B., A, C., B, D., Z, M., G, M., JF, N., R, V., J, K., P, L., C, S., C, D., S, A., S, P., A, L., D, M., LV, V., B, P., JD, L., E, T., X, D. L., O, L., Group, A. C., Group, A. C., centers, B. R., Laboratories, coordination, T., Sponsor, & Committee, S. (2022). Neutralizing antibodies against SARS-CoV-2 variants following mRNA booster vaccination in adults older than 65 years.. Scientific reports. https://doi.org/10.1038/s41598-022-24409-w

Source records